Support and Resistance Levels
Past performance
About Ind-Swift Laboratories Ltd Ind-Swift Laboratories Ltd, part of the Ind-Swift Group and founded in 1995, is a Chandigarh, India-based manufacturer of active pharmaceutical ingredients (APIs). The company boasts a diverse pipeline of 25 products, including antibiotics, anticholesterol, antihistamines, antidiabetics, anticancer, antidepressants, and antipsychotic drugs. Noteworthy products include Clarithromycin, Atorvastatin, and Letrozole. Ind-Swift has expanded its production capacities significantly over the years and enhanced its R&D capabilities, with notable facilities in Punjab and Himachal Pradesh. The company operates in over 40 countries and has subsidiaries in the US, India, and previously in Dubai and Singapore.
Ind-Swift has engaged in joint ventures to expand its market reach, particularly in the Middle East and Iran. The company has also entered new markets, such as phytochemicals, and has strategically adjusted its subsidiary portfolio. As of 2022, its subsidiaries include Ind-Swift Laboratories Inc. (US), Fortune (India) Constructions Limited, and Halcyon Life Sciences Pvt Ltd. Through these efforts, Ind-Swift aims to bolster its position in the pharmaceutical industry and explore new opportunities in the pharma field.